Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

Cara reports phase II topline data on oral Korsuva for pruritus in atopic dermatitis

April 29, 2021

Amgen initiates phase IIb trial of tezepelumab for chronic spontaneous urticaria

April 29, 2021

Hisamitsu reports phase III results with HP-5070 in primary palmar hyperhidrosis

April 28, 2021

China's NMPA approves IND for IL-23p19-targeting antibody NBL-012

April 28, 2021

Second pivotal study of IDP-126 achieves all coprimary endpoints with statistical significance

April 23, 2021

Baricitinib improves hair regrowth in patients with alopecia areata in second BRAVE-AA trial

April 21, 2021

First patients treated in phase I/II trial of pyrilutamide for acne in China

April 19, 2021

Genentech and Roche discover new KLK7-targeting antibodies

April 12, 2021

Allosteric MALT1 inhibitors from Toray Industries for the treatment of psoriasis

April 9, 2021

PXS-6302 enters first-in-human study for prevention of wound and burn scars

April 1, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 5, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...
How to Summit up? Dis-Harmoni on ivonescimab NSCLC phase III
BioWorld
Wall Street pundits were divided about the likely fate of ivonescimab, Summit Therapeutics Inc.’s bispecific antibody partnered with Akeso Pharmaceuticals Inc.,...